The most common symptom reported by healthcare workers was fatigue.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
Investigators with the United Kingdom's RECOVERY trial reported yesterday that a preliminary analysis of data from the azithromycin arm of the trial showed the antibiotic had no impact on clinical outcomes in hospitalized COVID-19 patients.
Vaccine arrived at 145 centers today, and 425 sites will get deliveries tomorrow.
Political affiliation appears to have more impact than local disease spread in 2 new studies.
Other regions considering further measures include London, Germany, Italy, and the Netherlands.
Data published late last week in the Centers for Disease Control and Prevention's (CDC's) Morbidity and Mortality Weekly Report (MMWR) detailed public school costs for recommended COVID-19 mitigation strategies, which averaged $442 per student but varied widely.
The step allows health workers to begin giving the vaccine and offers guidance on immunization policy.
Emergency approval makes the vaccine available and offers hope for altering the course of the pandemic.
Pressure over emergency use approval raises worries that the process has been rushed.
A study published yesterday in Science by researchers in Massachusetts suggests that a coronavirus outbreak linked to an international biotech conference in Boston in February is linked to more than 300,000 national and international infections with SARS-CoV-2, the virus that causes COVID-19.
In patients needing noninvasive breathing support, those who got the 2-drug combo recovered in 10 days, compared with 18 days for remdesivir alone.
